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Abstract: In this work, the in vitro anti-Leishmania activity of photodynamic liposomes made 
of soybean phosphatidylcholine, sodium cholate, total polar archaeolipids (TPAs) extracted 
from the hyperhalophile archaea Halorubrum tebenquichense and the photosensitizer zinc 
phthalocyanine (ZnPcAL) was compared to that of ultradeformable photodynamic liposomes 
lacking TPAs (ZnPcUDLs). We found that while ZnPcUDLs and ZnPcALs (130 nm mean 
diameter and −35 mV zeta potential) were innocuous against promastigotes, a low concentration 
(0.01 µM ZnPc and 7.6 µM phospholipids) of ZnPcALs irradiated at a very low-energy density 
(0.2 J/cm2) eliminated L. braziliensis amastigotes from J774 macrophages, without reducing the 
viability of the host cells. In such conditions, ZnPcALs were harmless for J774 macrophages, 
HaCaT keratinocytes, and bone marrow-derived dendritic cells. Therefore, topical photodynamic 
treatment would not likely affect skin-associated lymphoid tissue. ZnPcALs were extensively 
captured by macrophages, but ZnPcUDLs were not, leading to 2.5-fold increased intracellular 
delivery of ZnPc than with ZnPcUDLs. Despite mediating low levels of reactive oxygen 
species, the higher delivery of ZnPc and the multiple (caveolin- and clathrin-dependent plus 
phagocytic) intracellular pathway followed by ZnPc would have been the reason for the higher 
antiamastigote activity of ZnPcALs. The leishmanicidal activity of photodynamic liposomal 
ZnPc was improved by TPA-containing liposomes.
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Introduction
Latin America represents the most important endemic area of mucosal 
leishmaniasis,1 which manifests from days to years after cutaneous leishmaniasis (CL), 
and is known as classic mucocutaneous leishmaniasis (MCL) or espundia.2,3 MCL is a 
consequence of infection by New World Leishmania species, such as L. braziliensis, 
L. panamensis, L. amazonensis, and L. guyanensis.1,4 The mucosal lesions occurring 
during MCL are highly destructive, severely disfiguring, and potentially deadly. 
MCL represents a considerable health care problem in Latin America.5 Nowadays, 
leishmaniasis is largely moving towards domestic habitats,6,7 resulting in a marked 
MCL-incidence rise in Europe.8,9
Although there are no standardized protocols for the treatment of MCL,10 the World 
Health Organization recommends the use of intravenous pentavalent antimony and its 
derived molecules: sodium stibogluconate and meglumine antimoniate.11 Their killing 
mechanism is not known, and they are effective only on the intracellular forms – 
the amastigotes.12 For New World Leishmania species, their efficacy ranges from 
30% to 90%, and sodium stibogluconate appears to be less effective than meglumine 
antimoniate. Their usage is limited by resistance (significant in South America) 
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and cardiac, hepatic, hematic, pancreatic, and renal 
toxicity.13 Intravenous pentamidine11 possesses an efficacy 
of 90%–94% against L. braziliensis, but it is limited by 
resistance12 and severe toxicity.14,15 Other drugs of lower 
efficacy are miltefosine and paromomycin.16,17 Recently, 
an intravenous liposomal formulation of amphotericin B 
(AmBisome®; Astellas Pharma, Tokyo, Japan) was shown to 
be effective and better tolerated than sodium stibogluconate 
for treatment of CL due to L. braziliensis.18 Although 
AmBisome is claimed to be more cost effective than sodium 
stibogluconate treatment, the massive use of AmBisome is 
prohibitive for low-income people in South America. As a 
result of immunosuppression of human immunodeficiency 
virus-positive patients, kidney and heart recipients, and 
chronic users of corticosteroids, a serious risk of reactiva-
tion of CL in MCL form is present.19–23 On account of such 
complications, treatments should be started promptly after 
its diagnosis, so as to prevent mucosal metastasis.
In this scenario, photodynamic therapy (PDT) is an attrac-
tive therapeutic alternative that offers the opportunity of 
replacing parenteral administrations of leishmanicidal agents 
by the topical route. In PDT, photosensitizers (PS) are excited 
by light to produce cytotoxic reactive oxygen species (ROS) 
in the presence of oxygen.24 PDT has been widely used to 
eliminate diseased cells or pathogens, and has been employed 
with variable outcomes in experimental and clinical settings 
against CL.25 PDT could avoid the problem of drug resistance, 
since the generated ROS could target multiple sites on the 
parasite. Currently, four main classes of PS – porphyrin 
derivatives, chlorins, porphycenes, and phthalocyanines – 
have been approved by the US Food and Drug Administra-
tion for the clinical treatment of cancer.26,27 Among these, 
zinc phthalocyanine (ZnPc) exhibit a high photodynamic 
effect, as it possesses a diamagnetic Zn(II) central metal ion 
whose d-shell is fully occupied, by which the yield of triplet 
excited state and the long life essential for the generation of 
ROS becomes high.28 Moreover, ZnPc has a large absorption 
cross section of light at the tissue-penetrating spectral range 
of 650–900 nm.28,29
In the particular case of CL, the clinically relevant 
stage of the parasites are the intracellular amastigotes 
within phagolysosomes in dermal macrophages. Since the 
singlet oxygen has a radius of destruction of ~10–55 nm,30 
the phagolysosomal location of parasites could shield 
them from ROS generated in a distant site of the host cell. 
The subcellular targeting of PS depends on their chemical 
structure and significantly affects photodynamic proper-
ties. For example, mitochondrial localization has been 
observed for hydrophobic PS, such as ZnPc, chloroaluminum 
 phthalocyanine (ClAlPc), and protoporphyrin IX (PpIX),31,32 
in contrast to hydrophilic cationic phthalocyanines  localized 
preferentially within the lysosomes in some cancer cells.33,34 
Therefore, a strategy leading to target PS to the phagolyso-
somal machinery of the infected host cells could improve 
photodynamic activity against CL/MCL.
With the idea of a further topical treatment, we had 
already shown that in vitro activity of a hydrophobic ZnPc 
([tetrakis{2,4-dimetil-3-pentyloxi}-phthalocyaninate]zinc[II]) 
against L. braziliensis significantly improved when loaded in 
ultradeformable liposomes (UDLs; highly deformable lipo-
somes made of phospholipids [PLs] plus such edge activators 
as sodium cholate, Tween 80, or Span 80).35 In particular, these 
liposomes increased from 20% to 100% the antipromastigote 
activity and from 30% to 60% the antiamastigote activity (AA) 
of ZnPc, independently of irradiation. The increased AA of 
these UDLs was presumably due to their phagocytic uptake 
by the infected host cells. We later modified the UDL bilayer 
to get liposomes for topical application that were more exten-
sively taken up by phagocytic cells than UDLs themselves; 
these improved liposomes were dubbed ultradeformable 
archaeosomes (UDAs). The archaeosomes (ARCs) are vesicles 
made of total polar archaeolipids (TPAs) extracted from the 
hyperhalophile archaea Halorubrum tebenquichense. TPAs 
are a mixture of sn-2,3-glycerol ethers with polyisoprenoid 
chains, where phosphatidylglycerophosphate methyl ester and 
sulfated diglycosyl diphytanylglycerol diether (S-DGD-5) are 
the most abundant lipids. To prepare UDAs, half of the soybean 
phosphatidylcholine (SPC) of UDLs is replaced by TPAs at the 
ratio SPC:TPAs:sodium cholate (3:3:1 w:w). The UDAs were 
successfully used as antigen carriers for topical vaccination, 
because of their deep skin penetration and higher phagocytic 
uptake than UDLs, improving the antigen delivery to skin 
antigen-presenting cells.36 We hypothesized that TPAs contain-
ing liposomes could be used to increase the targeted delivery of 
ZnPc to macrophages to a higher extent than UDLs. Therefore, 
in this work, a commercial hydrophobic ZnPc was loaded into 
TPAs containing liposomes, and its in vitro leishmanicidal 
activity was compared to that of ZnPc loaded in UDLs on 
macrophages infected with L. braziliensis amastigotes.
Materials and methods
Materials
SPC (Phospholipon® 90 G, purity 90%) was a gift 
from Lipoid (Ludwigshafen, Germany). Sodium cholate 
(NaChol), 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-
N-(Lissamine™ [Thermo Fisher Scientific, Waltham, MA, USA] 
rhodamine B sulfonyl) (Rh-PE), ZnPc, mannan from Saccha-
romyces cerevisiae, 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyl 
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tetrazolium bromide (MTT), and Schneider’s Insect Medium 
were from Sigma-Aldrich (St Louis, MO, USA). 5-(and-6)-
chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate, acetyl 
ester (carboxy-H
2
DCFDA; Molecular Probes, Eugene, Oregon, 
USA), Roswell Park Memorial Institute (RPMI) 1640 and 
Modified Eagle’s Medium (MEM) were from Gibco®, Life 
Technologies (New York, USA). Fetal calf serum (FCS), 
antibiotic/antimycotic solution (penicillin 10,000 IU/mL, 
streptomycin sulfate 10 mg/mL, amphotericin B 25 µg/mL), 
glutamine, and trypsin/ethylenediaminetetraacetic acid were 
from PAA Laboratories GmbH (Pasching, Austria). Murine 
recombinant granulocyte-macrophage colony-stimulating factor 
was obtained from Pepro Tech (Rocky Hill, NJ, USA). Com-
plete RPMI (comp-RPMI) was prepared with RPMI 1640, 10% 
FCS, 5.5×10−5 M 2-mercaptoethanol from Sigma-Aldrich, and 
an antibiotic/antimycotic solution. Dendritic cell RPMI (DC-
RPMI) was prepared with comp-RPMI plus 20 ng/mL of murine 
recombinant granulocyte-macrophage colony-stimulating fac-
tor. All other chemicals and reagents were of analytical grade.
archaebacteria growth, extraction,  
and characterization of total polar lipids
Halorubrum tebenquichense Archaea, isolated from soil 
samples of Salina Chica, Península de Valdés, Chubut, 
Argentina was grown in 8 L batch cultures in basal medium 
supplemented with yeast extract and glucose.37 Cultures were 
monitored by absorbance at 660 nm and harvested in the late 
stationary phase for storage as frozen cell pastes.
Total lipids were extracted from frozen and thawed 
 biomass using the Bligh and Dyer method modified for 
extreme halophiles, and the TPA fraction was collected by 
precipitation from cold acetone.38 Between 90 mg and 120 mg 
TPAs were isolated from each culture batch. The reproduc-
ibility of each TPA-extract composition was routinely 
screened by phosphate content39 and electrospray-ionization 
mass spectrometry, as described in Higa et al.36
liposome preparation
Conventional liposomes (made of SPC), ARCs (made 
of TPAs), UDLs (made of SPC:NaChol, 6:1 w:w), and 
UDAs (made of TPAs:SPC:NaChol, 3:3:1 w:w:w) were 
prepared by the thin-film hydration method. To that end, 
appropriate amounts of lipids were dissolved in chloroform 
(SPC) or chloroform:methanol (1:1 vol:vol) (TPAs and 
NaChol) and mixed in round bottom flasks. Solvents were 
rotary-evaporated at 40°C, and the resultant lipid films 
flushed with N
2
 and hydrated with aqueous-phase (10 mM 
Tris-HCl buffer plus 0.9% w/vol NaCl, pH 7.4) buffer up 
to a final concentration of 43 mg of phospholipids/mL. 
The liposomal suspensions were sonicated (45 minutes with 
a bath-type sonicator, 80 W, 40 KHz) and extruded 15 times 
through three stacked 0.2 µm, 0.1 µm, and 0.1 µm pore 
polycarbonate filters using a 100 mL Thermobarrel extruder 
(Northern Lipids, Burnaby, Canada).
To prepare liposomes containing ZnPc, ZnPc was 
 dissolved in dimethylformamide at 0.5 mg/mL, and 170 µL 
was added to the organic solution of lipids to reach 2 mg 
ZnPc/g phospholipids (2.5 mmol ZnPc/mol phospholipids), 
and liposomes were prepared as stated earlier. To prepare 
Rh-PE-labeled liposomes, Rh-PE was dissolved in chloro-
form and 12.5 nmol was added to the organic solution of 
lipids (nearly 2,800:1 w:w phospholipids:Rh-PE); liposomes 
were prepared as stated earlier.
liposome characterization
PLs were quantified by a colorimetric phosphate microassay,39 
whereas ZnPc was quantified by absorbance at 667 nm upon 
complete disruption of one volume of liposomal suspension 
in 9 volumes of ethanol. Size and zeta potential were deter-
mined by dynamic light scattering and phase-analysis light 
scattering, respectively, using a Zetasizer Nano (Malvern 
Instruments, Malvern, UK).
The deformability value (D) of the liposomes was 
 calculated according to Van den Bergh40 as D = J (rv/rp)2, 
where J is the rate of penetration through a permeability 
barrier, rv is the size of vesicles after extrusion and rp is the 
pore size of the barrier. To measure J, vesicles were extruded 
through two stacked 50 nm (rp) membranes at 0.8 MPa using 
the Thermobarrel extruder (Northern Lipids, Burnaby, 
 Canada). Extruded volume was collected every minute 
for 15 minutes, PLs were quantified in each fraction, and J was 
calculated as the area under the curve of the plot of PLs recov-
ered as a function of time. The average vesicle diameter after 
extrusion (rv) was measured by dynamic light scattering.
cells and parasites
J774 and hacat cells
Immortalized murine BALsB/c monocyte/macrophage 
J774 and human keratinocytes (HaCaT cells), supplied by 
Dr Salvatierra of the Fundación Instituto Leloir (Buenos 
Aires, Argentina), were routinely cultured in RPMI 1640 or 
MEM supplemented with 10% FCS, 100 IU/mL penicillin, 
100 µg/mL streptomycin, and 2 mM glutamine at 37°C in 5% 
CO
2
 and 95% humidity.
Bone marrow-derived dendritic cells
Bone marrow-derived DCs were obtained as described 
previously.41 Briefly, cells obtained from femurs and tibias 





of mice were resuspended at 1×106 cells/mL in DC-RPMI. 
The culture medium was refreshed at 48-hour intervals 
for 6 days by repeating the same procedure. The plates 
were gently swirled to remove nonadherent granulocytes 
without dislodging clusters of developing DCs that were 
loosely attached to firmly adherent macrophages. Then, 80% 
of the media was aspirated and removed. Fresh DC-RPMI 
was added very slowly to avoid disrupting the clusters. At 
day 8, the cell aggregates were harvested by trypsinization 
for 5 minutes, followed by centrifugation as mentioned 
earlier and overnight subculture at 3×105 cells/mL in comp-
RPMI. The subcultures were fed at 48-hour intervals from 
days 10 to 14 with comp-RPMI. At days 10–14 of culture, 
cells were tested for specific markers. When more than 60% 
of the loosely adherent cells expressed the CD11c marker, 
they were considered ready to use.
Leishmania parasites
L. braziliensis promastigotes (strain HOM/BR75/M2903), 
supplied by Dr Mónica Esteva from the Instituto Nacional 
de Parasitologia Dr Mario Fatala Chabén (Buenos Aires, 
Argentina), were cultured at 26°C in Schneider’s Insect 
Medium supplemented with 10% FCS, 100 IU/mL penicil-
lin, 100 µg/mL streptomycin, and 2 mM glutamine. Growth 
curves of the parasite were performed, and promastigotes at 
the stationary phase were used for macrophage infection.
Uptake of liposomes by macrophages
The uptake of Rh-PE-labeled liposomes by macrophages 
was analyzed by flow cytometry. J774 cells seeded at a 
density of 3.5×105 cells per well onto six-well microplates 
were grown for 24 hours at 37°C. The medium was replaced 
with fresh MEM with 5% FCS containing Rh-PE-labeled 
liposomes, ARCs, UDLs, and UDAs at 0.5 mM PLs, 
and cells were incubated for 1, 3, and 5 hours at 37°C. After 
each incubation time, the medium was removed, cells were 
washed with phosphate-buffered saline (PBS; pH 7.4), and 
harvested by trypsinization. Cells were fixed in 1% formal-
dehyde at 4°C. Cells were washed, suspended in PBS, and 
a total of 1×105 cells were analyzed by flow cytometry (BD 
FACSCalibur™; BD Biosciences, San Jose, CA, USA). 
Data were analyzed using WinMDI 2.9 software (Microsoft, 
Redmond, WA, USA).
cytotoxicity on keratinocytes, 
macrophages, and dendritic cells
HaCaT and J774 cells and DC were seeded at a density 
of 5× and 9×104 cells per well, respectively, onto 96-well 
flat-bottom plates and grown for 24 hours at 37°C. Then, 
the medium was replaced by 100 µL of fresh medium with 
5% FCS containing 0.01 µM and 0.1 µM of free or liposomal 
ZnPc (corresponding to 7.6–5.2 µM PLs and 76–52 µM PLs). 
After 24-hour incubation at 37°C, suspensions were removed; 
cells were washed with PBS, and fresh MEM with 5% FCS 
was added. Cells were irradiated for 15 minutes with a halogen 
lamp (7748S 250 W; Philips, Amsterdam, the  Netherlands) 
that provided an average irradiance of 0.22 mW/cm2 
(measured with a SpectroSense2 light meter with an SKR 
110/SS2 sensor at 660 nm; Skye Instruments, Powys, UK) 
at a distance of 26 cm from the plates positioned per-
pendicularly to the center of the lamp. Illumination time 
of 15  minutes provided energy fluency of 0.2 J/cm2. 
Control cells were maintained without irradiation. After 
 irradiation, cells were incubated for 24 hours at 37°C, and 
then the medium was removed and replaced by 0.5 mg/mL 
of MTT. After 4 hours’ incubation, the MTT solution was 
removed, the insoluble formazan crystals were dissolved in 
dimethyl sulfoxide, and absorbance was measured at 570 nm 
in a microplate reader. The viability of cells was expressed as 
a percentage of the viability of cells grown in medium.
antipromastigote activity
L. braziliensis promastigotes (1×106) were incubated 
with 0.01 µM and 0.1 µM of free or liposomal ZnPc at 26°C 
in Schneider’s Insect Medium. After 24 hours’ incubation 
at 26°C, suspensions were removed; parasites were washed 
with PBS, fresh Schneider’s Insect medium with 5% FCS was 
added, and parasites were irradiated with 0.2 J/cm2. Control 
parasites were maintained without irradiation. After irradia-
tion, parasites were incubated for 24 hours at 26°C, and then 
parasite viability was measured by MTT assay.
antiamastigote activity
J774 cells were seeded at a density of 2×104 cells per well 
in eight-well culture-chamber slides (Nunc™ Lab-Tek™; 
Thermo Fisher Scientific), and grown for 24 hours at 37°C. 
Thereafter, J774 cells were infected for 4 hours with L. bra-
ziliensis promastigotes at a 1:6 macrophages:promastigotes 
ratio, and then extracellular parasites were removed by 
gently washing. The medium was replaced by 100 µL of 
fresh MEM with 5% FCS containing 0.01 µM and 0.1 µM 
of free or liposomal ZnPc. Cells were incubated for an addi-
tional 4 hours, and then irradiated with 0.2 J/cm2. Control 
cells were maintained without irradiation. After 24 hours, 
cells were washed with PBS, fixed with methanol, and stained 
with Giemsa. The number of amastigotes/100 cells was 
determined by counting at least 300 cells in triplicate cultures 
in each experimental condition by using light microscopy. 
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Untreated infected macrophages were used as controls. 
Antiamastigote activity was expressed as: %AA =(1−[{number 
of amastigotes/100 treated cells}/{number of amastigotes/100 
untreated cells} × 100]).
ZnPc delivery to macrophages
The uptake of free or liposomal ZnPc by J774 cells was 
analyzed by flow cytometry. Cells were seeded at a density 
of 1.5×105 cells per well onto 24-well plates and grown 
for 24 hours at 37°C. Then, the medium was replaced 
by 250 µL of fresh MEM with 5% FCS containing 0.01 µM 
of free or liposomal ZnPc (5.2–7.6 µM PL). After 24 hours’ 
incubation at 37°C, suspensions were removed, cells were 
washed with and suspended in PBS, and a total of 2×104 cells 
were analyzed by flow cytometry.
competition assay
J774 cells seeded at a density of 1.5×105 cells per well 
onto 24-well microplates were grown for 24 hours at 37°C. 
The medium was replaced with fresh MEM with 5% FCS 
containing 4 mg/mL mannan for 30 minutes. Then, 0.1 µM 
of liposomal ZnPc (corresponding to 76–52 µM PLs) was 
added and incubated for another 1 hour at 37°C. Cells were 
washed with PBS (pH 7.4) and harvested by trypsinization. 
Cells were suspended in PBS, and a total of 2×104 cells were 
analyzed by flow cytometry.
Measurement of reactive oxygen species
Carboxy-H
2
DCFDA dye was used to study intracellular ROS 
generation in J774 cells. Carboxy-H
2
DCFDA is a chemically 
reduced, acetylated form of fluorescein used as an indicator 
for ROS in cells. This nonfluorescent molecule is readily con-
verted to a green fluorescent form when the acetate groups are 
removed by intracellular esterases and oxidation (by the 
activity of ROS) occurs within the cell. Cells were seeded at a 
density of 1.5×105 cells per well onto 24-well plates 
and grown for 24 hours at 37°C. Then, the medium was replaced 
by 250 µL of fresh MEM with 5% FCS containing 0.01 µM 
and 0.1 µM of free or liposomal ZnPc. After 4 hours’ 
incubation at 37°C, suspensions were removed, cells were 
washed with PBS, and the medium was replaced by fresh 
MEM with 5% FCS. Cells were irradiated with 0.2 J/cm2. 
Control cells were maintained without irradiation. After 
irradiation, cells were incubated for 30 minutes at 37°C, and 
then the medium was removed and replaced by 10 µM of 
carboxy-H
2
DCFDA in PBS. After 30 minutes’ incubation, the 
solution was removed, cells were washed in and suspended in 
PBS, and a total of 2×104 cells were analyzed by flow cytom-
etry. As a positive control, intracellular ROS production was 




 for 30 minutes before 




Group means of results with two variables were evaluated 
by two-way analysis of variance (ANOVA) followed by 
Bonferroni correction, and results with one variable were 
evaluated by one-way ANOVA followed by Tukey’s test 
to compare individual groups using Prism 4.0 software 
(GraphPad Software, La Jolla, CA, USA). Significance levels 
are described in figure legends.
Results
characterization of liposomes
The main structural features of void and ZnPc-containing lipo-
somes are shown in Table 1. We found that the incorporation 
of ZnPc into the UDL bilayer did not significantly modify its 
deformability. However, the insertion of ZnPc into the UDA 
bilayer considerably reduced its deformability to the order of 
that of conventional liposomes. It is expected that a relative 
absence of postextrusion size reduction will be found, as long 
as the bilayers are highly deformable, as occurred with UDLs 
and UDAs, whose mean size was reduced by 0 and 15%, 
respectively. On the other hand, a significant size reduction 
upon extrusion is expected for poorly  deformable bilayers 
Table 1 structural characteristics of void and ZnPc containing liposomes. Values given are mean values of three different batches ± 
standard deviation of the mean











ls 109±5 (0.103) −10±3 62±6 765±267 –
UDls 110±2 (0.242) −12±2 109±2 3,882±291 –
UDas 130±1 (0.241) −35±4 110±2 4,064±365 –
ZnPcUDls 112±10 (0.10) −11±4 89±1 3,391±393 1.9±0.4
ZnPcals 131±19 (0.13) −35±1 96±1 425±130 1.4±0.7
Abbreviations: ls, conventional liposomes; UDls, ultradeformable liposomes; UDas, ultradeformable archaeosomes; ZnPcUDls, ZnPc containing ultradeformable 
liposomes; ZnPcals, ZnPc and archaeolipids containing liposomes.





such as liposomes and ZnPcALs, whose mean size was 
reduced by 43% and 27%, respectively. Another factor 
contributing to D is the flux (J) measured as the amount of 
filtered phospholipids/time. We found that 85% of the total 
ZnPcUDL phospholipids were filtered in the first 15 minutes, 
versus only 10% for ZnPcALs. Therefore, we will refer to 
these liposomes as ZnPcALs (instead of ZnPcUDAs), where 
ALs means archaeolipids containing liposomes.
Uptake of liposomes by macrophages
The phagocytic uptake of ARCs (nondeformable vesicles 
made of TPAs), UDAs (TPA-containing deformable 
vesicles), UDLs, and liposomes was compared. We found 
that ARCs and UDAs were extensively taken up, while the 
uptake of UDLs and liposomes was negligible (Figure 1). 
No significant difference was found between the uptake of 
UDAs or ARCs, their extensive phagocytosis likely related 
to the TPA content and not to their bilayer deformability. 
Therefore, despite not being deformable, ZnPcALs remained 
as suitable candidates as leishmanicidal liposomes to be taken 
up by infected macrophages.
cytotoxicity on keratinocytes, 
macrophages, and dendritic cells
Neither ZnPc in darkness or after irradiation nor ZnPc 
liposomes in darkness were cytotoxic on all cell types. 
After irradiation, 0.01 µM ZnPcUDLs and ZnPcALs were 
also innocuous on all cell types; however, at 0.1 µM, both 
decreased by 60% the viability of HaCaT cells (Figure 2A), 
and ZnPcALs decreased by 40% the viability of J774 cells 



















Figure 1 Uptake of rh-Pe-labeled liposomes by J774 cells as a function of time.
Notes: J774 cells were incubated with rh-Pe-ls, rh-Pe-UDls, rh-Pe-arcs, and rh-
Pe-UDas at 0.5 mM phospholipids in medium containing 5% Fcs. at different time 
points, cells were washed with phosphate-buffered saline, collected, fixed, and analyzed 
by flow cytometry (BD FACSCalibur™; BD Biosciences, San Jose, CA, USA).
Abbreviations: rh-Pe, dimyristoyl phosphoethanolamine-N-(lissamine rhodamine 
B sulfonyl); ls, conventional liposomes; UDls, ultradeformable liposomes; arcs, 
archaeosomes; UDas, ultradeformable archaeosomes; Fcs, fetal calf serum.






































































Figure 2 cytotoxicity of free and liposomal ZnPc on mammal cells in the darkness 
and after irradiation.
Notes: hacaT cells (A), J774 cells (B), and dendritic cells (C) were incubated with 
0.01 µM and 0.1 µM of ZnPc, ZnPcUDls, and ZnPcals for 24 hours in medium 
containing 5% Fcs. half the cells were kept in the darkness, and half were irradiated. 
after irradiation, cells were incubated for 24 hours in growth medium. cell survival 
was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
assay. Values represent means ± standard deviation (n=3). **P0.01; *P0.05.
Abbreviations: ZnPc, zinc phthalocyanine; ZnPcUDls, ZnPc containing ultrad-
eformable liposomes; ZnPcals, ZnPc and archaeolipids containing liposomes; Fcs, 
fetal calf serum.
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(Figure 2B). ZnPcUDLs and ZnPcALs were not cytotoxic 
on DCs (Figure 2C) in darkness or after irradiation, indi-
cating therefore a lower sensitivity to liposomal PDT than 
macrophages and keratinocytes.
antipromastigote activity
Neither ZnPc nor ZnPc liposomes reduced the viability of 
L. braziliensis promastigotes in darkness or after irradiation 
(Figure 3).
antiamastigote activity
Interestingly, we found a basal concentration- and irradiation- 
independent AA of around 25% for UDLs, UDAs, and 
ZnPc. Similarly, the 50%–60% AA of ZnPcUDLs was 
 concentration- and irradiation-independent as well (Figure 4A). 
The 85%–90% AA of ZnPcALs at 0.1 µM ZnPc was also 
irradiation-independent. However, the 15% AA of ZnPcALs 
at 0.01 µM ZnPc in darkness significantly increased to 
near 90% after irradiation. Optical microscopy of infected mac-
rophages treated with 0.01 µM ZnPc (Figure 4B) and 0.01 µM 
ZnPcALs (Figure 4C) after irradiation showed the preservation 
of intact morphology of macrophages, together with a reduction 
in the number of amastigotes per macrophage.
ZnPc delivery to macrophages
The amount of ZnPc delivered by ZnPcALs to J774 cells 
was quantified by flow cytometry of the fluorescent ZnPc, 





















Figure 3 cytotoxicity of free and liposomal ZnPc on Leishmania braziliensis 
promastigotes in the darkness and after irradiation.
Notes: L. braziliensis promastigotes were incubated with 0.01 µM and 0.1 µM 
of ZnPc, ZnPcUDls, and ZnPcals for 24 hours in schneider’s Insect Medium 
(sigma aldrich, st louis, MO, Usa) at 26°c. half the parasites were kept in darkness, 
and half were irradiated. after irradiation, parasites were incubated for 24 hours 
in growth medium. cell survival was determined by the 3-(4,5-dimethylthiazol- 
2-yl)-2,5-diphenyltetrazolium bromide assay. Values represent means ± standard 
deviation (n=3).
Abbreviations: ZnPc, zinc phthalocyanine; ZnPcUDls, ZnPc containing ultrad-
eformable liposomes; ZnPcals, ZnPc and archaeolipids containing liposomes.



























Figure 4 antiamastigote activity of free or liposomal ZnPc in the darkness and 
after irradiation.
Notes: (A) J774 cells previously infected with Leishmania braziliensis promastigotes 
were incubated with 0.01 µM (I) and 0.1 µM (II) of ZnPc, ZnPcUDls, and ZnPcals, 
and with void liposomes (UDls and als at the phospholipid concentrations 7.6–5.2 
[I] µM and 76–52 [II] µM) for 4 hours in medium containing 5% fetal calf serum. 
half the cells were kept in darkness, and half were irradiated. after irradiation, 
cells were incubated for 24 hours in growth medium. Then cells were fixed with 
methanol and stained with giemsa (Merck, New Jersey, Usa). The number of 
amastigotes/100 cells was determined by counting at least 300 cells in three different 
experiments, and antiamastigote activity was calculated. (B,C) Optical microscopy 
of infected J774 cells incubated with 0.01 µM ZnPc (B) and 0.01 µM ZnPcals (C), 
both taken 24 hours after irradiation. arrows points to intracellular amastigotes. 
*P0.05; ***P0.001.
Abbreviations: ZnPc, zinc phthalocyanine; ZnPcUDls, ZnPc containing ultrad-
eformable liposomes; ZnPcals, ZnPc and archaeolipids containing liposomes; UDls, 
ultradeformable liposomes; als, archaeolipids containing liposomes.
and was 2.5-fold higher than that delivered by ZnPcUDLs or 
ZnPc (Figure 5A). Remarkably, the uptake of ZnPcALs and 
not of ZnPcUDLs was strongly reduced in the presence of the 
mannose polysaccharide yeast mannan (Figure 5B).
Production of rOs
Only macrophages treated with 0.1 µM ZnPcALs generated 
measurable levels of ROS in an irradiation-independent 
fashion (Figure 6).
Discussion
In this work, based on the hypothesis that TPAs containing 
liposomes could improve ZnPc delivery to infected mac-
rophages, the in vitro leishmanicidal activity of ZnPcALs 
was compared to that of ZnPcUDLs and free ZnPc on 
 macrophages infected with L. braziliensis.














































Figure 5 Uptake of liposomal ZnPc by J774 cells.
Notes: (A) J774 cells were incubated with 0.01 µM of ZnPc, ZnPcUDls, and ZnPcals for 24 hours in medium containing 5% fetal calf serum (Fcs). Then, cells were washed 
with phosphate-buffered saline (PBS), suspended in PBS, and analyzed by flow cytometry (BD FACSCalibur™; BD Biosciences, San Jose, CA, USA). (B) J774 cells were 
preincubated with 4 mg/ml mannan for 30 minutes in medium containing 5% Fcs, then 0.1 µM of ZnPcUDls and ZnPcals were added and incubated for another hour 
at 37°C. Then, cells were washed with PBS, suspended in PBS, and analyzed by flow cytometry. Values represent mean ± standard deviation (n=3). ***P0.001.
Abbreviations: ZnPc, zinc phthalocyanine; ZnPcUDls, ZnPc containing ultradeformable liposomes; ZnPcals, ZnPc and archaeolipids containing liposomes; Ns, not 
significant.




















Figure 6 reactive oxygen species (rOs) production of J774 cells after treatment 
with free or liposomal ZnPc in darkness and after irradiation.
Notes: J774 cells were incubated with 0.01 µM and 0.1 µM of ZnPc, ZnPcUDls, and 
ZnPcals for 4 hours in medium containing 5% fetal calf serum. half the cells were 
kept in darkness, and half were irradiated. after irradiation, cells were incubated 
for 30 minutes at 37°c, and then medium was removed and replaced by 10 µM 
of (5-and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate, acetyl ester in 
phosphate-buffered saline (PBs). Then, cells were washed with PBs, suspended in 
PBS, and analyzed by flow cytometry (BD FACSCalibur™; BD Biosciences, San Jose, 
ca, Usa). Values represent means ± standard deviation (n=3). **P0.01.
Abbreviations: ZnPc, zinc phthalocyanine; ZnPcUDls, ZnPc containing ultrad-
eformable liposomes; ZnPcals, ZnPc and archaeolipids containing liposomes.
First we found that insertion of ZnPc into the UDA bilayer 
considerably reduced its deformability. Bilayer deformability 
depends on the mixing/demixing of edge activators (EAs; 
hydrophilic detergents, such as sodium cholate, deoxy-
cholate, or Tween 80) as a response to mechanical defor-
mation stress.42,43 However, the lateral mobility of foreign 
molecules dissolved within polyisoprenoid lipids rich in 
sugar, such as TPA bilayers, is low. In a previous work, we 
observed that the addition of EAs to pure TPA bilayers does 
not lead to highly deformable liposomes, due to the impaired 
lateral mobility (mixing/demixing) of EAs in TPAs. In order 
to make TPA bilayers highly deformable, a minimal propor-
tion of SPC is required at 3:1:3 w:w SPC:NaChol:TPAs. 
Below that SPC threshold, the presence of EAs is insuf-
ficient to make the TPA bilayer highly deformable. SPC 
is therefore unavoidable, since the mixing of EAs occurs after 
the TPA is diluted in a given amount of SPC.44 It is likely, 
therefore, that the insertion of hydrophobic ZnPc within the 
TPA–SPC mixture interfered with EA demixing, decreasing 
its deformability.
On the other hand, we found that the intracellular 
ZnPc delivered to macrophages by 0.01 µM ZnPcALs was 
2.5-fold higher than that delivered by ZnPcUDLs or ZnPc. 
We also observed that after irradiation at 0.2 J/cm2 fluency, 
the AA of 0.01 µM ZnPcALs was 60% higher than with 
ZnPc and 35% higher than with ZnPcUDLs. Although free 
ZnPc or ZnPcUDLs delivered the same amount of intracel-
lular ZnPc, the higher AA of ZnPcUDLs could be due to the 
different intracellular localization of ZnPc. While free ZnPc 
enters by diffusion,45 ZnPcUDLs are taken up by clathrin-
mediated endocytosis, the ZnPc delivered to intracellular 
targets being different to those by diffusion.46 Instead, the 
higher AA of 0.01 µM ZnPcALs than ZnPcUDLs would 
be a consequence of the higher ZnPc endocytic uptake of 
the mannosylated liposomes following particular intracel-
lular traffic. It was recently reported that 100 nm-diameter 
TPAs containing liposomes were taken up by J774 cells 
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by multiple pathways that included phagocytosis and 
clathrin- and caveolin- mediated endocytosis (Defain et al, 
unpublished data, 2014). The  mannose receptor (MR) 
expressed in J774 is involved in high endocytic uptake 
of mannosylated ligands.47 The uptake of ZnPcALs was 
strongly reduced via coadministration with mannan, indi-
cating that internalization of ZnPcALs was mediated by 
the mannose receptor. The high uptake of TPAs contain-
ing liposomes, ARCs, UDAs, and ZnPcALs suggested an 




α-D-glucose]-2,3-di-O-phytanyl-sn-glycerol) and the MR, 
primarily expressed by macrophages, DCs, and some epithe-
lial cells.48 Remarkably, a high uptake plus the noninduction 
of proinflammatory cytokines are hallmarks of the interaction 
via MR,49–51 and we have recently observed that despite being 
highly taken up, UDAs did not induce the proinflammatory 
cytokines tumor necrosis factor-α and interleukin 6 by 
J774 cells (Perez et al, unpublished data, 2014).
The PDT with 0.01 µM liposomal ZnPc resulted in 
toxicity to intracellular parasites, but was innocuous for 
host macrophages and keratinocytes. Remarkably, primary 
DCs – a cell type expected to be target of TPAs containing 
liposomes, due to their constitutive expression of MR48 – 
showed surprising resistance to the liposomal PDT. This 
would suggest that further topical PDT would not affect the 
immune functions of skin-associated lymphoid tissue.
Interestingly, we found that irradiation with liposomal 
ZnPc significantly inhibited the survival of amastigotes inside 
host macrophage, cells but had no antipromastigote effect. 
Similar results were found for paromomycin-containing 
liposomes and transfersomes, where activities against intra-
cellular L. major amastigotes were higher than activities 
against promastigotes.52,53
Quantitative comparisons of our results with other contri-
butions are difficult to establish, due to the scarcity of studies 
on the activity of ZnPc-mediated PDT against New World 
leishmaniasis. Our in vitro results showed that 0.01 µM 
ZnPcAL-mediated PDT at 0.2 J/cm2 was deleterious against 
intracellular amastigotes and kept viable macrophages, 
keratinocytes, and dendritic host cells. Interestingly, this 
was achieved at a 100-fold lower dose of PS (1.25 µM) 
and 75-fold lower fluency (15 J/cm2) than we have reported 
before with ZnPcUDLs ([tetrakis{2,4-dimetil-3-pentyloxi}-
phthalocyaninate] zinc [II]).35 On the other hand, our results 
were achieved at 104–105-fold lower doses of PS (1 mM 
δ-aminolevulinic acid [ALA] and 1 mM PpIX) and 50–100-
fold lower fluency (50–10 J/cm2) than with ALA or PpIX, 
that had previously failed to eliminate intracellular L. major 
amastigotes.54,55 With such an approach, macrophages were 
more sensitive than the parasites to ALA, suggesting that 
death of the host cells likely occurred without complete 
eradication of the parasites. Our results also were achieved at 
a 180-fold lower dose and 5.5- to eleven-fold lower fluency 
than with liposomal carbaporphyrin dimethyl ketal, which 
showed a half-maximal effective concentration of 1.8 µM 
against intracellular L. amazonensis amastigotes.56 Finally, 
our results were achieved at a seven- to 15-fold higher dose 
than with liposomal AlPcCl, which showed half-maximal 
inhibitory concentrations of 1.49 and 0.69 nM against 
intracellular L. panamensis and L. chagasi amastigotes, 
respectively.57 Nonetheless, these were similar to the 
half-maximal cytotoxicity concentration on macrophages 
(1.35 nM). This means that the uninfected macrophages 
were eliminated by similar (or quite a lot lower) concen-
tration of ClAlPc than intracellular amastigotes. These 
kinds of results were also reported for free ALA58 and 
AlPcCl.59 In all cases, our results were achieved at 34-fold 
lower fluency without reducing macrophage viability.
Unfortunately, in studies that used PDT as a leishmani-
cidal agent, the measurement of intracellular ROS was 
avoided.54–59 However, at 0.01 µM ZnPcALs, the induction 
of AA in response to irradiation suggested the mediation of 
ROS that produced below the minimal detection level of the 
method60 and was lethal for intracellular amastigotes. Here, 
carboxy-H
2
DCFDA (used to detect hydrogen peroxide; per-
oxyl radicals, including alkyl peroxyl and hydroperoxyl; and 
peroxynitrite anions in cell-free systems) showed quantita-
tive and irradiation-independent ROS production by 0.1 µM 
ZnPcALs. After irradiating 0.01 µM ZnPcALs, however, no 
ROS were detected. The results could be interpreted as aris-
ing from a chemotoxic, concentration-dependent instead of a 
photodynamic activity. A partial explanation for this would lie 
in the fact that ROS can be produced in the dark by chemical 
reactions and not exclusively by photodynamic activity.
In general, the endocytic uptake of liposomes results in 
therapeutic effects with minimal amounts of active  principle, 
because of selective delivery to intracellular targets. In our 
case, PDT with 0.01 µM ZnPcALs combined a high amount of 
intracellular ZnPc with a probable local generation of ROS at 
multiple intracellular targets by phagocytosis and clathrin- and 
caveolin-mediated endocytosis that was lethal for amastigotes. 
Our finding of a high AA of 0.01 µM ZnPC-UDLs indepen-
dent of irradiation suggested the intervention of chemotoxic-
ity and not ROS-mediated mechanisms. Similarly, Taylor 
et al56 reported that the activity of liposomal carbaporphyrin 
dimethyl ketal on intracellular amastigotes of L. amazonensis 
was irradiation-independent, and when tested in vivo using 





a hamster model of CL with L. amazonensis, carbaporphyrin 
ketals were active even in the dark. The authors suggested 
that the compound, once metabolized in the animal tissue, 
produces an active ingredient that does not seem to be pho-
tosensitive. Nonetheless, the increased AA after irradiation 
of 0.01 µM ZnPcALs strongly suggested the intervention 
of photoinduction, although our experimental setting was 
unable to show a ROS increment as a response to irradiation. 
A potential explanation would be that the intracellular delivery 





DCFDA) to the parasite 
lipids, nucleic acids, and proteins, resulting in minimal ROS 
production. The results at 0.1 µM ZnPcALs could be explained 
by the superimposition of phototoxicity and chemical toxicity 
that could also be mediated by ROS in the dark.
Finally, at 0.1 µM liposomal ZnPc in the dark, the intra-
cellular parasites were affected, while the host cells suffered 
no damage. After irradiation, however, ZnPcUDLs damaged 
keratinocytes, while ZnPcALs damaged keratinocytes and 
macrophages as well. These in vitro assays would suggest 
that in vivo, the dosage scheme will have to be adjusted in 
order to achieve leishmanicidal activity, but also to avoid 
potential epidermal cytotoxicity.
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